![Nathaniel Kim](https://www.mskcc.org/sites/default/files/styles/large/public/node/183685/main_image/kim-nathaniel_191120_04_1200x800.jpg)
My interests lie at the interface of Chemistry and Cancer Metabolism. C13-labeled MR contrast agents are synthesized for the non-invasive diagnosis of redox state in tumors. The information gained is then leveraged for the long-term treatment of pancreatic and colon cancer.